Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on saxagliptin versus vildagliptin in poorly controlled type 2 diabetes
ChiCTR-TRC-13003858Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of saxagliptin and vildagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Glycosylated hemoglobin. Started Nov 2013; status: completed.
02
Drugs
saxagliptinvildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-13003858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003858.